carbidopa has been researched along with Depression in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (50.00) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamed, M; Lazarescu, A; Shetty, A; Suchowersky, O; Tremain, G | 1 |
| Bellante, F; Dethy, S; Zegers de Beyl, D | 1 |
| Chigir', IP; Fedorova, NV | 1 |
| Herkes, GK; McKay, D; Meagher, LJ; Needham, M | 1 |
| Eriksson, E; Modigh, K | 1 |
| Calne, DB; Chuang, LW; Eisler, T; Karoum, F; Klein, DF; Liebowitz, MR; Quitkin, FM; Wyatt, RJ | 1 |
| van Hiele, LJ | 1 |
| Carter, JH; Maricle, RA; Nutt, JG | 1 |
| Lang, A; Männistö, PT; Rauhala, P; Vasar, E | 1 |
| Olanow, CW | 1 |
| Barchas, JD; Berger, PA; Brodie, KH; Sack, R; Zarcone, VP | 1 |
| Garfinkel, PE; Stancer, HC; Warsh, JJ | 1 |
| Brown, GM; Garfinkel, PE; Stancer, HC; Warsh, JJ | 1 |
| Marsden, CD; Mindham, RH; Parkes, JD | 1 |
| Garfinkel, PE; Sibony, D; Stancer, HC; Warsh, JJ | 1 |
| Joly, P; Lampert, A; Lauret, P; Thomine, E | 1 |
| Driver, PS | 1 |
| Dick, P; Eisenring, JJ; Tissot, R; Yanniotis, G | 1 |
1 review(s) available for carbidopa and Depression
| Article | Year |
|---|---|
Depression, alpha 2-receptors and sex hormones: neuroendocrine studies in rat.
Topics: Animals; Antidepressive Agents; Apomorphine; Carbidopa; Castration; Clonidine; Depression; Dihydrotestosterone; Fenclonine; Gonadal Steroid Hormones; Growth Hormone; Humans; Male; Pituitary Gland, Anterior; Rats; Receptors, Adrenergic, alpha; Reserpine; Testosterone | 1984 |
3 trial(s) available for carbidopa and Depression
| Article | Year |
|---|---|
The indoleamine hypothesis of depression: an overview and pilot study.
Topics: 5-Hydroxytryptophan; Adult; Aged; Carbidopa; Clinical Trials as Topic; Depression; Female; Homovanillic Acid; Humans; Hydroxycorticosteroids; Hydroxyindoleacetic Acid; Male; Middle Aged; Models, Neurological; Serotonin | 1977 |
Psychiatric symptoms during l-dopa therapy for Parkinson's disease and their relationship to physical disability.
Topics: Aged; Amantadine; Carbidopa; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Interview, Psychological; Levodopa; Male; Mental Status Schedule; Methyldopa; Middle Aged; Parkinson Disease; Placebos; Recurrence; Trihexyphenidyl | 1976 |
Depression treatment in Parkinson's disease.
Topics: Antidepressive Agents, Tricyclic; Carbidopa; Depression; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Humans; Levodopa; Nortriptyline; Parkinson Disease | 1991 |
14 other study(ies) available for carbidopa and Depression
| Article | Year |
|---|---|
A case of Perry Syndrome responding to intestinal infusion of carbidopa/levodopa.
Topics: Antiparkinson Agents; Carbidopa; Depression; Drug Combinations; Female; Gels; Humans; Hypoventilation; Infusions, Parenteral; Jejunostomy; Levodopa; Middle Aged; Parkinsonian Disorders | 2019 |
Depression, anxiety and non-motor symptoms on initiation of intrajejunal levodopa/carbidopa therapy.
Topics: Adult; Aged; Antiparkinson Agents; Anxiety; Carbidopa; Depression; Drug Combinations; Female; Humans; Jejunum; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Psychiatric Status Rating Scales; Time Factors | 2016 |
[Dopamine receptors agonists (mirapex) in the treatment of Parkinson's disease].
Topics: Anxiety; Benzothiazoles; Carbidopa; Delayed-Action Preparations; Depression; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Receptors, Dopamine D1; Thiazoles; Treatment Outcome | 2006 |
Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy.
Topics: Acetaminophen; Acyclovir; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Anxiety Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiparkinson Agents; Antiviral Agents; Anxiety; Carbidopa; Ceftriaxone; Cervical Vertebrae; Depression; Dexamethasone; Diazepam; Doxepin; Electroconvulsive Therapy; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Oxycodone; Pain; Parkinson Disease; Selegiline; Spinal Injuries | 2006 |
Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Amphetamines; Biogenic Amines; Carbidopa; Depression; Drug Combinations; Female; Humans; Levodopa; Male; Methamphetamine; Middle Aged; Monoamine Oxidase; Parkinson Disease; Phenethylamines; Selegiline; Tyramine | 1982 |
l-5-Hydroxytryptophan in depression: the first substitution therapy in psychiatry? The treatment of 99 out-patients with 'therapy-resistant' depressions.
Topics: 5-Hydroxytryptophan; Adult; Age Factors; Aged; Antidepressive Agents; Carbidopa; Depression; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Sex Factors | 1980 |
Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: preliminary findings.
Topics: Affect; Aged; Anxiety; Arousal; Carbidopa; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease | 1995 |
Beneficial effects of co-administration of catechol-O-methyltransferase inhibitors and L-dihydroxyphenylalanine in rat models of depression.
Topics: Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Depression; Desipramine; Dihydroxyphenylalanine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Levodopa; Male; Motor Activity; Nitriles; Nitrophenols; Rats; Rats, Wistar; Swimming; Tolcapone | 1995 |
A 61-year-old man with Parkinson's disease.
Topics: 1-Naphthylamine; Antiparkinson Agents; Carbidopa; Depression; Dopamine Agents; Drug Interactions; Drug Therapy, Combination; Family Practice; Humans; Levodopa; Male; Middle Aged; Neurology; Neuroprotective Agents; Parkinson Disease; Selegiline; Sertraline; Vitamin E | 1996 |
Depression: new evidence in support of biological differentiation.
Topics: Adult; Bipolar Disorder; Carbidopa; Depression; Female; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Tryptamines; Tryptophan | 1979 |
Neuroendocrine responses to carbidopa in primary affective dosorders.
Topics: Adult; Bipolar Disorder; Carbidopa; Depression; Dopamine Antagonists; Female; Growth Hormone; Hormones; Humans; Hydrocortisone; Male; Prolactin; Serotonin Antagonists; Thyrotropin | 1979 |
Total and free plasma tryptophan levels in patients with affective disorders: effects of a peripheral decarboxylase inhibitor.
Topics: Adolescent; Adult; Bipolar Disorder; Carbidopa; Depression; Female; Humans; Hydrazines; Male; Middle Aged; Tryptophan | 1976 |
Development of pseudobullous morphea and scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
Topics: 5-Hydroxytryptophan; Aged; Carbidopa; Chronic Disease; Depression; Drug Therapy, Combination; Eosinophilia-Myalgia Syndrome; Humans; Male; Parkinson Disease; Scleroderma, Localized | 1991 |
[Combination of L-dopa, desipramine, and a decarboxylase inhibitor in the treatment of depression (author's transl)].
Topics: Adult; Aged; Anxiety; Carbidopa; Carboxy-Lyases; Depression; Desipramine; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Humans; Hydrazines; Male; Middle Aged | 1973 |